Particle therapy in Europe.

Area of Science:

• Oncology and Radiation Physics

Background:

• Particle therapy represents an advanced radiotherapy modality utilizing protons or heavier ions.
• It offers enhanced precision in dose deposition, characterized by the Bragg peak, minimizing radiation exposure to healthy tissues compared to traditional X-ray therapy.
• Biological benefits arise from the high linear energy transfer (LET) of charged particles near the Bragg peak.

Purpose of the Study:

• To review the fundamental principles of particle therapy.
• To present current clinical applications and ongoing research within Europe.
• To outline the established networks facilitating particle therapy access and development.

Main Methods:

• Literature review of particle therapy concepts.
• Analysis of current clinical indications and European research initiatives.
• Overview of established clinical facilities and collaborative networks.

Main Results:

• Particle therapy provides superior dose localization and biological effectiveness.
• Despite a slow initial introduction in Europe, there has been a significant expansion, with over 20 clinical facilities established in the last decade.
• Increased access to particle therapy has facilitated clinical research and patient treatment.

Conclusions:

• Particle therapy is a leading radiotherapy technique with significant advantages for cancer care and research.
• The growth of clinical facilities in Europe is enhancing accessibility and driving further research.
• Established networks are crucial for the continued development and implementation of particle therapy.